Science progresses when people share what they learn, not when they retreat behind borders or institutions. That was true when my colleagues and I first discovered a protein, known today as ...

Despite 40 years of intense research, the urgently-needed vaccine for HIV still eludes us. Therefore, it’s crucial that an Env-targeting HIV vaccine induces broadly neutralizing antibodies (bnAbs) ...

Add Yahoo as a preferred source to see more of our stories on Google. For decades, public health efforts across sub-Saharan Africa have focused on HIV prevention, testing and treatment campaigns on ...

Frimpong’s invited commentary discusses the significance of a major efficacy trial involving the game Tumaini and what it ...

As we begin to focus on the psychological impact of all the illness and death in the COVID-19 pandemic, there’s much we can learn from the still-ongoing HIV-AIDS pandemic whose 40th anniversary we ...

Launched with fanfare in December, the city’s new HIV/AIDS curriculum drew scorn from many health advocates at a panel Wednesday night. “AIDS is more than a science project,” said Joe Pressley, ...

Ending the U.S. HIV Epidemic: Wafaa El-Sadr discusses an ambitious new HIV goal for the United States and lessons to be learned from the global HIV response.

Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town Nomathemba Chandiwana receives research ...

CAB-LA, the two-monthly HIV prevention injection, was approved in South Africa over three years ago but never reached government clinics. As lenacapavir prepares to launch, CAB-LA's quiet exit carries ...